A phase 2 study of pegylated interferon α-2b (PEG-Intron(®)) in children with diffuse intrinsic pontine glioma.
about
Trial WatchTherapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosisClinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma.Diffusion tensor histogram analysis of pediatric diffuse intrinsic pontine gliomaBrainstem glioma: a review.NK cell-based immunotherapies in Pediatric Oncology.Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain InhibitionDiffuse intrinsic pontine glioma: poised for progress.Immunotherapy in pediatric malignancies: current status and future perspectivesPediatric diffuse intrinsic pontine glioma: can optimism replace pessimism?Pediatric brainstem gliomas: new understanding leads to potential new treatments for two very different tumors.Managing teenage/young adult (TYA) brain tumors: a UK perspective.Immunotherapy for brain tumors: understanding early successes and limitations.Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review).Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.
P2860
Q24618653-5E0EC2A2-67F7-47BA-9B8D-C707B8B83744Q30357776-E297FC3B-0020-448F-9A03-E1D171EF1EBEQ30652433-7627802D-1F1B-4F4A-9305-0849AC1F8E7BQ33810394-1B2D40DA-8517-4B3D-8C8D-D45D32E5BFF7Q34628180-CC332B50-6083-4553-8114-2087184428A5Q35600975-6A682168-3154-42B8-9C70-396FA9A78D6EQ36130555-86BFC9C1-E7C1-47D8-A8A3-ECCFE68A54C6Q36492719-43F46022-9988-43BA-BAE9-AA6A8DE146E6Q36691818-5A6EA744-86EB-4EA1-BAF0-D96D591F9FFAQ38233425-4C620721-A8E9-44F4-9A18-5AA64F4577A7Q38363549-7CC1541E-3266-475F-A34B-192EA3A5FB6FQ38539466-5F25D2DE-41FB-455F-8E60-AEC26AE664FAQ47555498-8CA4C58E-095E-467E-A443-8ED6AEE61127Q52683991-D1880080-2880-4B21-9597-31109F6F1415Q55456557-7D5A1622-8A07-4E0A-9C84-456B98B918DC
P2860
A phase 2 study of pegylated interferon α-2b (PEG-Intron(®)) in children with diffuse intrinsic pontine glioma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A phase 2 study of pegylated i ...... fuse intrinsic pontine glioma.
@ast
A phase 2 study of pegylated i ...... fuse intrinsic pontine glioma.
@en
type
label
A phase 2 study of pegylated i ...... fuse intrinsic pontine glioma.
@ast
A phase 2 study of pegylated i ...... fuse intrinsic pontine glioma.
@en
prefLabel
A phase 2 study of pegylated i ...... fuse intrinsic pontine glioma.
@ast
A phase 2 study of pegylated i ...... fuse intrinsic pontine glioma.
@en
P2093
P2860
P356
P1433
P1476
A phase 2 study of pegylated i ...... fuse intrinsic pontine glioma.
@en
P2093
Alisa Prager
Joanna Shih
Katherine Warren
Kevin Camphausen
Pamela L Wolters
Robyn Bent
Roger Packer
Ryan Hanson
P2860
P304
P356
10.1002/CNCR.26659
P407
P577
2011-11-15T00:00:00Z